目录号 | 产品详情 | 靶点 | |
---|---|---|---|
T79080 | ROCK | ||
ROCK-IN-7(compound 9)作为ROCK激酶抑制剂,主要应用于眼部疾病(包括青光眼及视网膜疾病)的研究领域。 | |||
T63637 | |||
ROCK-IN-4 是 ROCK 的有效抑制剂,可维持 NO 释放能力。ROCK-IN-4 能够可逆地解聚 F-肌动蛋白,并阻碍人小梁网 (HTM) 细胞的线粒体呼吸。ROCK-IN-4 能够用于研究青光眼或高眼压。 | |||
T79833 | ROCK | ||
ROCK-IN-9(Compound T345)为ROCK抑制剂。该化合物在HepG2细胞中表现出IC50为40.8 μM的细胞毒性。在小鼠模型中,ROCK-IN-9展现了良好的药代动力学特性,即使在低剂量下也能获得较高的体内暴露水平及口服生物利用度。 | |||
T7648 | Myosin PKA PKC | ||
HA-100 是蛋白激酶和ROCK 抑制剂,抑制PKG,PKA,PKC 和MLC 激酶的IC50值分别为 4、8、12 和 240 μM。 | |||
T70937 | |||
ROCK-IN-(R)14f is a potent ROCK inhibitor. | |||
T23308 | ROCK | ||
SAR407899 hydrochloride 是一种选择性,ATP 竞争性的ROCK 抑制剂,对人和大鼠ROCK2的Ki 值分别为 36 和 41 nM,对ROCK2的IC50值为 135 nM。 | |||
T13384L | CaMK ROCK PKC | ||
Y-33075 dihydrochloride 是一种选择性ROCK 抑制剂,IC50为 3.6 nM。 | |||
T7764 | ROCK Rho Ras | ||
CCG-222740 是一种口服有效的选择性Rho/MRTF 途径抑制剂。它也是 α-平滑肌的肌动蛋白表达抑制剂,可减少皮肤纤维化并阻止黑色素瘤转移。 | |||
T2482 | ROCK SGK Akt PKA S6 Kinase | ||
AT13148 是一种 ATP 竞争性 AGC 激酶口服抑制剂,能够抑制 Akt1/Akt2/Akt3、p70S6K、PKA 和 ROCKI/ROCKII 的活性,IC50值分别为 38/402/50、8、3 和 6 nM/4 nM。 | |||
T4276L | ROCK PKA | ||
Hydroxyfasudil (Hydroxy-Fasudil) 是一种ROCK 抑制剂,对ROCK1和ROCK2的IC50分别为 0.73 和 0.72 μM。 |
目录号 | 产品名/同用名 | 种属 | 表达系统 | ||
---|---|---|---|---|---|
TMPH-03265 | CMKLR2 Protein, Rat, Recombinant (His) | Rat | in vitro E. coli expression system | ||
Receptor for chemoattractant adipokine chemerin/RARRES2 suggesting a role for this receptor in the regulation of inflammation and energy homesotasis. Signals mainly via beta-arrestin pathway. Binding of RARRES2 activates weakly G proteins, calcium mobilization and MAPK1/MAPK3 (ERK1/2) phosphorylation too. Acts also as a receptor for TAFA1, mediates its effects on neuronal stem-cell proliferation and differentiation via the activation of ROCK/ERK and ROCK/STAT3 signaling pathway.
|
|||||
TMPH-01805 | ODAM Protein, Human, Recombinant (His) | Human | E. coli | ||
Tooth-associated epithelia protein that probably plays a role in odontogenesis, the complex process that results in the initiation and generation of the tooth. May be incorporated in the enamel matrix at the end of mineralization process. Involved in the induction of RHOA activity via interaction with ARHGEF and expression of downstream factors such as ROCK. Plays a role in attachment of the junctional epithelium to the tooth surface.
|
|||||
TMPH-02697 | GNA12 Protein, Mouse, Recombinant (His & Myc) | Mouse | E. coli | ||
Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems. Activates effector molecule RhoA by binding and activating RhoGEFs (ARHGEF12/LARG). GNA12-dependent Rho signaling subsequently regulates transcription factor AP-1 (activating protein-1). GNA12-dependent Rho signaling also regulates protein phosphatese 2A activation causing dephosphorylation of its target proteins. Promotes tumor cell invasion and metastasis by activating RhoA/ROCK signaling pathway and up-regulating proinflammatory cytokine production. Inhibits CDH1-mediated cell adhesion in process independent from Rho activation. Together with NAPA promotes CDH5 localization to plasma membrane. May play a role in the control of cell migration through the TOR signaling cascade.
|